Agenus reports 3-year survival data for colorectal cancer drug combo

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. INTC
6. GOOG
7. AMD
8. CSX
9. IBM
10. KNX

Go back to Agenus reports 3-year survival data for colorectal cancer drug combo
AGENUS (NASDAQ: AGEN) Delayed: 6.19 +0.66 (11.93%)
Previous Close $5.53    52 Week High $7.49 
Open $5.53    52 Week Low $2.61 
Day High $6.23    P/E N/A 
Day Low $5.46    EPS $-1.10 
Volume 2,332,499